Evaluación de un programa de Atención: Farmacéutica en pacientes con Diabetes Mellitus Tipo 2

Maidana, GM; Lugo, GB; Vera, Z; Pérez, S; Mastroianni, PC.
Pharm. care Esp ; 18(1): 3-5, 2016. tab
Artigo em Espanhol | IBECS (Espanha) | ID: ibc-149612

Documentos relacionados

  1. A New Drug Target for Type 2 Diabetes.
  2. Influence of autozygosity on common disease risk across the phenotypic spectrum.
  3. Insights from multi-omics integration in complex disease primary tissues.
  4. MINERAL WATER "DZUGURI" AND TYPE 2 DIABETES MELLITUS: SCREENING RESULTS.
  5. Relationship between trajectories of dietary iron intake and risk of type 2 diabetes mellitus: evidence from a prospective cohort study.
  6. Workplace Interventions for Type 2 Diabetes Mellitus Prevention-an Umbrella Review.
  7. Population segmentation of type 2 diabetes mellitus patients and its clinical applications - a scoping review.
  8. Menopause and diabetes.
  9. The Role of Physicians' Digital Tools in Pharmacological Management of Type 2 Diabetes Mellitus.
  10. Management of separated endodontic instruments: case reports.